Response-adapted anti-PD-1 based salvage therapy for Hodgkin lymphoma with nivolumab alone or in combination with ICE

Results of a study examining nivolumab combined with chemotherapy for treatment of relapsed Hodgkin lymphoma. (Abstract only)